| Term 
 | Definition 
 
        | *relax muscle spasms *prevent and treat malignant hyperthermia |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Expected Pharmacologic Action |  | Definition 
 
        | *inhibit release of calcium *blocks muscle contraction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *muscle weakness *drowsy, dizzy *diarrhea *liver toxicity (w/ higher doses and long term) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *monitor for: diarrhea, drowsiness, muscle strength, liver function tests *start oral doses low and ↑ slow |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *oral: given 1-2 days preop *IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Report: weakness, prolonged diarrhea *Avoid: driving, CNS depressants (ETOH) *Potential liver damage |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | * ♥ disease * lung disease *neuromuscular disorders *pts older than 35yo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *estrogen ↑ risk of liver toxicity *CNS depressants (ETOH) ↑ risk of severe sedations *IV use: calcium channel blockers ↑ risk of severe dysrhythmias |  | 
        |  |